Influences on antidepressant prescribing trends in the UK: 1995–2011

Social Psychiatry and Psychiatric Epidemiology

Volumn 52, Issue 2, 2017, Pages 193-200

  Mars, Becky ^a   Heron, Jon ^a   Kessler, David ^a   Davies, Neil M ^a,b   Martin, Richard M ^a   Thomas, Kyla H ^a   Gunnell, David ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Antidepressants; General practice; Prescribing; Primary care; Trends

Indexed keywords

ANTIDEPRESSANT AGENT;

HUMAN; PRESCRIPTION; PRIMARY HEALTH CARE; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TRENDS; UNITED KINGDOM;

ANTIDEPRESSIVE AGENTS; DRUG PRESCRIPTIONS; HUMANS; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; UNITED KINGDOM;

EID: 84996799548     PISSN: 09337954     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00127-016-1306-4     Document Type: Article

References (41)

1. Olfson M, Marcus SC (2009) National patterns in antidepressant medication treatment. Arch Gen Psychiatry 66(8):848–856
2. Mojtabai R, Olfson M (2014) National trends in long-term use of antidepressant medications: results from the US National Health and Nutrition Examination Survey. J Clin Psychiatry 75(2):169–177
3. Ilyas S, Moncrieff J (2012) Trends in prescriptions and costs of drugs for mental disorders in England, 1998–2010. Br J Psychiatry 200(5):393–398
4. Lockhart P, Guthrie B (2011) Trends in primary care antidepressant prescribing 1995–2007: a longitudinal population database analysis. Br J Gen Pract 61(590):e565–e572
5. Noordam R et al (2015) Prescription and indication trends of antidepressant drugs in the Netherlands between 1996 and 2012: a dynamic population-based study. Eur J Clin Pharmacol 71(3):369–375
6. González-López M et al (2015) Trends in the dispensation of antidepressant drugs over the past decade (2000–2010) in Andalusia, Spain. Soc Psychiatry Psychiatr Epidemiol 50(5):705–712
7. Sihvo S et al (2010) Increase in the duration of antidepressant treatment from 1994 to 2003: a nationwide population-based study from Finland. Pharmacoepidemiol Drug Saf 19(11):1186–1193
8. Meijer WE et al (2004) Incidence and determinants of long-term use of antidepressants. Eur J Clin Pharmacol 60(1):57–61
9. Exeter D, Robinson E, Wheeler A (2009) Antidepressant dispensing trends in New Zealand between 2004 and 2007. Aust N Z J Psychiatry 43(12):1131–1140
10. Raymond CB, Morgan SG, Caetano PA (2007) Antidepressant utilization in British Columbia from 1996 to 2004: increasing prevalence but not incidence. Psychiatr Serv 58(1):79–84
11. Moore M et al (2009) Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database. BMJ 339:b3999
12. Kendrick T et al (2015) Did NICE guidelines and the quality outcomes framework change GP antidepressant prescribing in England? Observational study with time trend analyses 2003–2013. J Affect Disord 186:171–177
13. Munoz-Arroyo R et al (2006) Exploring potential explanations for the increase in antidepressant prescribing in Scotland using secondary analyses of routine data. Br J Gen Pract 56(527):423–428
14. Cruickshank G et al (2008) Cross-sectional survey of patients in receipt of long-term repeat prescriptions for antidepressant drugs in primary care. Ment Health Fam Med 5(2):105
15. Mojtabai R, Olfson M (2011) Proportion of antidepressants prescribed without a psychiatric diagnosis is growing. Health Aff 30(8):1434–1442
16. Rait G et al (2009) Recent trends in the incidence of recorded depression in primary care. Br J Psychiatry 195(6):520–524
17. Wijlaars L, Nazareth I, Petersen I (2012) Trends in depression and antidepressant prescribing in children and adolescents: a cohort study in The Health Improvement Network (THIN). PLoS One 7(3):e33181
18. Kendrick T et al (2015) Changes in rates of recorded depression in English primary care 2003–2013: time trend analyses of effects of the economic recession, and the GP contract quality outcomes framework (QOF). J Affect Disord 180:68–78
19. Great Britain. Key health statistics from General Practice (1998) Analysis of morbidity and treatment data, including time trends, England and Wales 2000. Office for National Statistics, London
20. Herrett E et al (2015) Data resource profile: clinical practice research datalink (CPRD). Int J Epidemiol 44(3):827–836
21. Joint Formulary Committee (2015) British national formulary, vol 69. BMJ Group and Pharmaceutical Press, London
22. Kim HJ et al (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:335–351
23. Health and Social Care Information Centre. Read codes. http://systems.hscic.gov.uk/data/uktc/readcodes. Accessed 3 Aug 2016
24. Rush AJ et al (2006) Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology 31(9):1841–1853
25. Zhong W et al (2014) Time trends of antidepressant drug prescriptions in men versus women in a geographically defined US population. Arch Women’s Ment Health 17(6):485–492
26. Middleton N et al (2001) Secular trends in antidepressant prescribing in the UK, 1975–1998. J Public Health 23(4):262–267
27. Serna MC et al (2010) Duration and adherence of antidepressant treatment (2003 to 2007) based on prescription database. Eur Psychiatry 25(4):206–213
28. Pratt LA, Brody DJ, Gu Q (2011) Antidepressant use in persons aged 12 and over: United States, 2005–2008. NCHS Data Brief 76:1–8
29. Mittal M et al (2014) National antidepressant prescribing in children and adolescents with mental health disorders after an FDA boxed warning. Res Soc Adm Pharm 10(5):781–790
30. Gibbons RD et al (2007) Early evidence on the effects of regulators’ suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry 164(9):1356–1363
31. Bergen H et al (2009) Trends in prescribing and self-poisoning in relation to UK regulatory authority warnings against use of SSRI antidepressants in under-18-year-olds. Br J Clin Pharmacol 68(4):618–629
32. Dean AJ, Hendy A, McGuire T (2007) Antidepressants in children and adolescents—changes in utilisation after safety warnings. Pharmacoepidemiol Drug Saf 16(9):1048–1053
33. Murray ML et al (2005) Effects of the Committee on Safety of Medicines advice on antidepressant prescribing to children and adolescents in the UK. Drug Saf 28(12):1151–1157
34. Lu CY et al (2014) Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study. BMJ 348:g3596
35. Valuck RJ et al (2007) Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry 164(8):1198–1205
36. Wheeler BW et al (2008) The population impact on incidence of suicide and non-fatal self harm of regulatory action against the use of selective serotonin reuptake inhibitors in under 18s in the United Kingdom: ecological study. BMJ 336(7643):542–545
37. Windfuhr K, While D, Hunt I, Shaw J, Appleby L, Kapur N (2013) Suicides and accidental deaths in children and adolescents. Arch Dis Child. doi:10.1136/archdischild-2012-302539
38. The Nuffield Trust and Health Foundation (2014) QualityWatch. Focus on: antidepressant prescribing. http://www.qualitywatch.org.uk/sites/files/qualitywatch/field/field_document/140528_QualityWatch_Focus%20on_antidepressant%20prescribing_0.pdf. Accessed 23 Sep 2015
39. Sreeharan V et al (2013) Improving access to psychological therapies and antidepressant prescribing rates in England: a longitudinal time-series analysis. Br J Gen Pract 63(614):e649–e653
40. National Institute for Clinical Excellence (2009) Depression in adults. the treatment and management of depression in adults. http://www.nice.org.uk/guidance/cg90/resources/guidance-depression-in-adults-pdf. Accessed 23 Sep 2015
41. Petty DR et al (2006) Prevalence, duration and indications for prescribing of antidepressants in primary care. Age Ageing 35(5):523–526